T. Kızılay Et Al. , "Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study.," European neurology , 2024
Kızılay, T. Et Al. 2024. Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study.. European neurology .
Kızılay, T., Akbayir, E., Erol, R., Demir, A. S., Özkan Yaşargün, D., Yilmaz, V., ... Tuzun, E.(2024). Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study.. European neurology .
Kızılay, Tuğçe Et Al. "Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study.," European neurology , 2024
Kızılay, Tuğçe Et Al. "Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study.." European neurology , 2024
Kızılay, T. Et Al. (2024) . "Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study.." European neurology .
@article{article, author={Tuğçe Kızılay Et Al. }, title={Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study.}, journal={European neurology}, year=2024}